| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/17/2013 | US20130018104 Emulsive composition containing dapsone |
| 01/17/2013 | US20130018079 Antimicrobial compositions and methods of use thereof |
| 01/17/2013 | US20130018067 Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 01/17/2013 | US20130018066 Heterocyclic aspartyl protease inhibitors |
| 01/17/2013 | US20130018050 Bi-functional pyrazolopyridine compounds |
| 01/17/2013 | US20130018049 Azaindole Compounds and Methods for Treating HIV |
| 01/17/2013 | US20130018044 New inhibitors of cyclophilins and uses thereof |
| 01/17/2013 | US20130018042 Toll-Like Receptor Agonist Formulations and Their Use |
| 01/17/2013 | US20130018029 High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds |
| 01/17/2013 | US20130018026 Halogenated phenols for diagnostics, antioxidant protection and drug delivery |
| 01/17/2013 | US20130018018 Novel nucleoside phosphonates and analogs |
| 01/17/2013 | US20130018015 Nutritional Composition and Methods of Making and Using Same |
| 01/17/2013 | US20130018013 Bicyclic nucleosides and nucleotides as therapeutic agents |
| 01/17/2013 | US20130018011 Method of treating dengue fever |
| 01/17/2013 | US20130018010 Polymeric conjugates of adenine nucleoside analogs |
| 01/17/2013 | US20130018008 Crystalline forms of a macrolide, and uses therefor |
| 01/17/2013 | US20130018007 Modified Saponins for the Treatment of Fungal Infections |
| 01/17/2013 | US20130018000 Recombinant filaggrin polypeptides for cell importation |
| 01/17/2013 | US20130017991 Hcv protease inhibitors and uses thereof |
| 01/17/2013 | US20130017263 Gastric acid secretion inhibiting composition |
| 01/17/2013 | US20130017262 Immediate/delayed drug delivery |
| 01/17/2013 | US20130017261 Use of lactobacillus for treatment of virus infections |
| 01/17/2013 | US20130017255 Tamper Resistant Dosage Form Comprising an Adsorbent and an Adverse Agent |
| 01/17/2013 | US20130017253 Inducing Cellular Immune Responses to Human Papillomavirus Using Peptide and Nucleic Acid Compositions |
| 01/17/2013 | US20130017227 Wound healing compositions and associated methods |
| 01/17/2013 | US20130017217 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
| 01/17/2013 | US20130017216 Modified Influenza Virus For Monitoring And Improving Vaccine Efficiency |
| 01/17/2013 | US20130017215 Secreted campylobacter flagella coregulated proteins as immunogens |
| 01/17/2013 | US20130017214 Bacteremia-associated antigen from staphylococcus aureus |
| 01/17/2013 | US20130017210 Display of antibody fragments on virus-like particles of rna bacteriophages |
| 01/17/2013 | US20130017204 Genes of an Otitis Media Isolate of Nontypeable Haemophilus Influenzae |
| 01/17/2013 | US20130017203 Methods of treating and preventing staphylococcus aureus infections and associated conditions |
| 01/17/2013 | US20130017201 Bispecific monoclonal antibody capable of cross reacting with lethal factor (lf) and edema factor (ef), and neutralizing edema toxin (et) as well as lethal toxin (lt) of bacillus anthracis |
| 01/17/2013 | US20130017199 Simultaneous inhibition of pd-l1/pd-l2 |
| 01/17/2013 | US20130017197 Stabilized antibody preparations and uses thereof |
| 01/17/2013 | US20130017189 Functionalised Triblock Copolymers and Compositions Containing Such Polymers |
| 01/17/2013 | US20130017174 Compositions and methods for increasing health and reducing pathogenic bacteria in animals |
| 01/17/2013 | US20130017173 Novel compositions and methods for treating inflammatory bowel disease and airway inflammation |
| 01/17/2013 | US20130017171 Methods and compositions for treating hepatitis c virus |
| 01/17/2013 | US20130017170 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 01/17/2013 | US20130017163 Halogenated phenols for diagnostics, antioxidant protection and drug delivery |
| 01/17/2013 | US20130017156 Cefdinir and cefixime formulations and uses thereof |
| 01/17/2013 | US20130014759 Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (vap) and ventilator associated tracheal (vat) bronchitis |
| 01/17/2013 | CA2841983A1 Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 01/17/2013 | CA2841890A1 Hbv polymerase mutants |
| 01/17/2013 | CA2841540A1 Inhibitors of bacterial type iii secretion system |
| 01/17/2013 | CA2841487A1 Inhibitors of bacterial type iii secretion system |
| 01/17/2013 | CA2841356A1 Parenteral norovirus vaccine formulations |
| 01/17/2013 | CA2841095A1 Spiro compounds as hepatitis c virus inhibitors |
| 01/17/2013 | CA2840445A1 Thiophen-2-carboxylic acid derivatives useful as inhibitors of flaviviridae viruses |
| 01/17/2013 | CA2839747A1 Eosinophil peroxidase compositions and methods of their use |
| 01/17/2013 | CA2838999A1 Human binding molecules capable of neutralizing influenza a viruses of phylogenetic group 1 and phylogenetic group 2 and influenza b viruses |
| 01/16/2013 | EP2546246A2 Compounds and methods for the treatment or prevention of flavivirus infections |
| 01/16/2013 | EP2546234A1 Nitrogeneous heterocyclic derivative and medicine containing the same as an active ingredient |
| 01/16/2013 | EP2545924A1 Method for the prevention and treatment of sepsis. |
| 01/16/2013 | EP2545923A1 Antibacterial agents |
| 01/16/2013 | EP2545899A1 Composition for the prophylaxis of candidiasis |
| 01/16/2013 | EP2545081A1 Free hexasaccharide isolated from several campylobacter species |
| 01/16/2013 | EP2545060A1 Fused tricyclic silyl compounds and methods of use thereof for the treatment of viral diseases |
| 01/16/2013 | EP2545051A1 Compounds for the treatment of hepatitis c |
| 01/16/2013 | EP2545049A1 Crystalline salts of a potent hcv inhibitor |
| 01/16/2013 | EP2545047A1 Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
| 01/16/2013 | EP2545042A1 Compounds for the treatment of hepatitis c |
| 01/16/2013 | EP2544711A1 Treatment of streptococcal infections |
| 01/16/2013 | EP2544689A2 Solid compositions |
| 01/16/2013 | EP2544669A1 Adhesive patch for therapeutic agent delivery |
| 01/16/2013 | EP2544660A2 Rifaximin ready-to-use suspension |
| 01/16/2013 | EP2544659A2 Highly permeating terbinafine formulation for treating onychomycosis |
| 01/16/2013 | CN202666022U Microcapsule structure with black fungus extraction liquid |
| 01/16/2013 | CN202666019U Microcapsule containing nanometer metal liquid |
| 01/16/2013 | CN102884079A Compositions and methods for treating hepatitis virus infection |
| 01/16/2013 | CN102884075A Method for inhibiting HIV replication in mammal and human cells |
| 01/16/2013 | CN102884064A Processes for the preparation of S1P1 receptor modulators and crystalline forms thereof |
| 01/16/2013 | CN102884058A 1-cyclopropyl-8-methyl-7-[5-methyl-6-(methylamino)-3-pyridinyl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid salts |
| 01/16/2013 | CN102884053A Cyclopropanecarboxylic acid derivative |
| 01/16/2013 | CN102884035A Synthesis of magnolol and its analogue compounds |
| 01/16/2013 | CN102883727A Materials and methods for prevention and treatment of viral infections |
| 01/16/2013 | CN102883718A Analogues for the treatment or prevention of flavivirus infections |
| 01/16/2013 | CN102876715A Retroviral vector for gene therapy for tuberculosis and HIV (Human Immunodeficiency Virus) coinfection and application thereof |
| 01/16/2013 | CN102876707A Preparation method of recombinant poliovirus I-type virus-like particles |
| 01/16/2013 | CN102876699A Method for establishing transgenic cell line of target genes shRNA (short hairpin ribonucleic acid) interfering propagation of porcine reproductive and respiratory syndrome viruses |
| 01/16/2013 | CN102876688A Method for preparing recombinant polio I virus-like particles |
| 01/16/2013 | CN102876675A Peptide nucleic acid for subgroup J avian leukosis viruses and application of peptide nucleic acid |
| 01/16/2013 | CN102876638A Recombinant influenza virus capable of realizing high-efficiency expression of HA protein, and preparation method and application of recombinant influenza virus |
| 01/16/2013 | CN102876620A Nontoxic ST28 streptococcus suis and application thereof |
| 01/16/2013 | CN102876456A Method for extracting volatile oil and alkaloid from pepper by using subcritical fluid |
| 01/16/2013 | CN102875674A Anti-tetanotoxin antibody, and preparation method and application thereof |
| 01/16/2013 | CN102875667A HIV-1 (human immunodeficiency virus-1) peptide Env120-128 specificity TCR (T cell receptor), recombinant retroviral vector thereof and application |
| 01/16/2013 | CN102875666A Tuberculosis antigen specificity TCR (T cell receptor), recombinant retroviral vector thereof and application |
| 01/16/2013 | CN102875660A Virus induced protein Mig1 and application thereof |
| 01/16/2013 | CN102875659A Antibacterial peptide secreted by skins of northeast forest frog, and coding sequence and application thereof |
| 01/16/2013 | CN102875642A Compounds for enzyme inhibition |
| 01/16/2013 | CN102875628A (20S,24S)-ocotillol ginsenoside derivatives with antibacterial activity, and preparation method and application thereof |
| 01/16/2013 | CN102875576A Synthesis of antibiotic ceftazidime, ceftazidime for injection and preparation method of ceftazidime |
| 01/16/2013 | CN102875575A Cefodizime sodium compound and preparation thereof |
| 01/16/2013 | CN102875573A Cefixime compound and pharmaceutical composition thereof |
| 01/16/2013 | CN102875528A Quinolone metal complex containing polyacid anion and preparation method thereof |
| 01/16/2013 | CN102875518A Genipin methyl ether, preparation method and medicine application thereof |
| 01/16/2013 | CN102875513A Microcrystal catechin and preparation method thereof |
| 01/16/2013 | CN102875474A Novel naphthenic amine compound for heteromorphosis-resistant influenza viruses |